(19)
(11) EP 4 554 620 A1

(12)

(43) Date of publication:
21.05.2025 Bulletin 2025/21

(21) Application number: 23839071.0

(22) Date of filing: 14.07.2023
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
(52) Cooperative Patent Classification (CPC):
Y02A 50/30; C07K 2317/24; C07K 16/2803; C07K 2317/92; C07K 2317/55; C07K 2299/00; C07K 2317/30; C07K 2317/41; C07K 2317/52; C07K 2317/732; C07K 2317/734; C07K 2317/70; A61K 2039/507; C07K 16/2818; A61K 2039/505
(86) International application number:
PCT/CN2023/107563
(87) International publication number:
WO 2024/012584 (18.01.2024 Gazette 2024/03)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 15.07.2022 WO PCT/CN2022/105904
30.03.2023 WO PCT/CN2023/084985

(71) Applicant: BeiGene Switzerland GmbH
4051 Basel (CH)

(72) Inventors:
  • DING, Xiao
    Beijing 102206 (CN)
  • REN, Zhiying
    Beijing 102206 (CN)
  • SONG, Jing
    Beijing 102206 (CN)
  • SUN, Jian
    Beijing 102206 (CN)
  • XUE, Liu
    Beijing 102206 (CN)
  • YANG, Xiao
    Beijing 102206 (CN)
  • ZHANG, Jing
    Beijing 102206 (CN)
  • CHEN, Xin
    Beijing 102206 (CN)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) METHODS OF CANCER TREATMENT USING ANTI-TIGIT ANTIBODIES